CB
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Challenging Reported Frizzled-Targeting Compounds in Selective Assays Reveals Lack of Functional Inhibition and Claimed Profiles | ACS pharmacology & translational science |  | 2024 | 197 | 115 | ||
| Wnt-pathway inhibitors with selective activity against triple-negative breast cancer: from thienopyrimidine to quinazoline inhibitors | Frontiers in pharmacology | | 2022 | 215 | 218 | ||
| Unlocking the Wnt pathway : therapeutic potential of selective targeting FZD7 in cancer | Drug discovery today | | 2021 | 548 | 534 |
